Accumulating evidence indicates that immune dysfunction is associated with autism disorders in a significant subset of children. Previous reports have shown abnormal immunoglobulin (Ig) levels, including an increased presence of autoreactive antibodies in the circulation of individuals with autism. As IgG is the predominant antibody isotype in circulation, we expected that an altered immune response could result in an abnormal IgG subclass profile in children with autism. We examined circulating plasma levels of IgG1, IgG2, IgG3, and IgG4 in 241 children from the CHARGE (Childhood Autism Risks from Genetics and the Environment) study, a large epidemiologic case-control investigation, including 114 children who meet full criteria for autism disorder (AU), 96 typically developing control children (TD) from a randomly selected sample of the general population, and 31 children with developmental delays (DD). We report significantly increased levels of the IgG4 subclass in children with AU compared with TD control children (p = 0.016) and compared with DD controls (p = 0.041). These results may suggest an underlying immunological abnormality in AU subjects resulting in elevated IgG4 production. Further investigation is necessary to elucidate the relationship between immunological findings and behavioral impairments in autism.
Behavior ADOS a b s t r a c t Accumulating evidence indicates that immune dysfunction is associated with autism disorders in a significant subset of children. Previous reports have shown abnormal immunoglobulin (Ig) levels, including an increased presence of autoreactive antibodies in the circulation of individuals with autism. As IgG is the predominant antibody isotype in circulation, we expected that an altered immune response could result in an abnormal IgG subclass profile in children with autism. We examined circulating plasma levels of IgG1, IgG2, IgG3, and IgG4 in 241 children from the CHARGE (Childhood Autism Risks from Genetics and the Environment) study, a large epidemiologic case-control investigation, including 114 children who meet full criteria for autism disorder (AU), 96 typically developing control children (TD) from a randomly selected sample of the general population, and 31 children with developmental delays (DD). We report significantly increased levels of the IgG4 subclass in children with AU compared with TD control children (p = 0.016) and compared with DD controls (p = 0.041). These results may suggest an underlying immunological abnormality in AU subjects resulting in elevated IgG4 production. Further investigation is necessary to elucidate the relationship between immunological findings and behavioral impairments in autism.
Ó 2009 Elsevier Inc. All rights reserved.
Introduction
Autism spectrum disorders are a group of relatively common pervasive neurodevelopmental disorders affecting between 2 and 6 children per 1000 (Chakrabarti and Fombonne, 2005; Fombonne, 2005; Yeargin-Allsopp et al., 2003) . Autism presents early in childhood and is characterized by deficits in verbal and non-verbal communication, restricted and repetitive stereotypical patterns of behavior, and impairments in social interactions. The etiology of autism is unknown with both environmental and genetic factors considered to play key roles. Multiple genetic studies of children and adults with autism have indicated various candidate genes, many of them related to immune system function, including C4 null allele and MHC haplotypes B44-SC30-DR4, HLA-DR b1, DR4, and DR13 (Daniels et al., 1995; Ferrante et al., 2003; Lee et al., 2006; Torres et al., 2006; Warren et al., 1995) . Other genes that have important roles in regulating the developing immune system, such as MET, PTEN and RELN have also been implicated in autism (Beilmann et al., 1997; Butler et al., 2005; Garbett et al., 2008; Pardo and Eberhart, 2007; Skaar et al., 2005) . Environmental triggers, such as thalidomide, valproic acid, and prenatal and early postnatal infections have also been associated with autism (Ashwood et al., 2006; Fortier et al., 2007; Meyer et al., 2006; Miyazaki et al., 2005; Narita et al., 2002; Niehus and Lord, 2006; Rodier et al., 1997; Rosen et al., 2007; Shi et al., 2003; Vojdani et al., 2003; Williams et al., 2001) . Evidence includes increased rates of infection in neonates who were later diagnosed with autism, (Rosen et al., 2007) , and links with congenital rubella, cytomegalovirus and other viral infections (Chess, 1971; Stubbs et al., 1984) . In addition, several researchers have described various immune abnormalities, including increased levels of inflammatory mediators and the presence of autoimmune phenomena (Ashwood et al., 2006; Cohly and Panja, 2005; Korvatska et al., 2002) . Taken together, these findings suggest that immunological imbalances or alterations during critical neurodevelopmental junctures could be important in a significant subset of children with autism.
Descriptions of aberrant immune function in individuals with autism have been reported for nearly 40 years. Among these findings there has been a long standing focus on autoimmune processes in individuals with autism and/or their primary and secondary family members compared with the general population 
